Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators

NCT00703313 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 1.5% levofloxacin ophthalmic solution
DRUG: 0.5% moxifloxacin hydrochloride ophthalmic solution
DRUG: 0.3% gatifloxacin ophthalmic solution

Sponsor

Santen Inc.